株式会社ONODERA GT Pharma

1 known investors

A gene therapy company developing treatments for neurodegenerative diseases, with a pipeline of more than ten programs led by candidates for ALS and Parkinson's disease. It aims to bring these therapies into clinical practice to reduce patient suffering.

BiotechHealthtechMedical Devices